Dynavax Technologies Corporation (DVAX)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	848,941	926,241	882,012	851,286	859,120	835,666	797,460	830,141	683,841	932,944	955,405	940,515	607,285	852,670	583,906	427,533	228,725	290,003	265,466	194,147
Total current liabilities	US$ in thousands	78,634	70,030	62,192	56,002	62,195	54,264	44,862	91,515	150,074	244,080	345,198	466,203	556,402	528,935	204,642	109,422	77,411	66,625	53,222	29,279
Current ratio		10.80	13.23	14.18	15.20	13.81	15.40	17.78	9.07	4.56	3.82	2.77	2.02	1.09	1.61	2.85	3.91	2.95	4.35	4.99	6.63

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $848,941K ÷ $78,634K
= 10.80

The current ratio of Dynavax Technologies Corporation has displayed fluctuating trends over the past few years. It stood at a relatively high level of 6.63 as of March 31, 2020, indicating a strong ability to meet its short-term obligations with its current assets. However, the ratio declined to 1.09 by December 31, 2021, suggesting a potential strain on the company's liquidity position.

From the beginning of 2022, there was a gradual improvement in the current ratio, reaching 15.20 by March 31, 2024. This significant increase indicates a substantial enhancement in the company's short-term liquidity and ability to cover its current liabilities using its current assets.

Overall, the current ratio of Dynavax Technologies Corporation has experienced considerable fluctuations, reflecting changes in the company's liquidity position over the analyzed period. It is essential for investors and stakeholders to closely monitor this ratio to assess the company's ability to meet its short-term financial obligations.